Memphasys Limited (ASX:MEM)

Australia flag Australia · Delayed Price · Currency is AUD
0.0060
-0.0005 (-7.69%)
Mar 6, 2026, 2:41 PM AEST
-14.29%
Market Cap 17.08M
Revenue (ttm) 213.98K
Net Income (ttm) -4.41M
Shares Out 2.85B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 105,694
Average Volume 2,453,537
Open 0.0070
Previous Close 0.0065
Day's Range 0.0060 - 0.0070
52-Week Range 0.0030 - 0.0110
Beta 0.37
RSI 48.38
Earnings Date Mar 3, 2026

About Memphasys

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals. In addition, the company develops ambient temperature storage p... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2006
Employees 24
Stock Exchange Australian Securities Exchange
Ticker Symbol MEM
Full Company Profile

Financial Performance

In fiscal year 2025, Memphasys's revenue was 526,921, an increase of 237.77% compared to the previous year's 156,000. Losses were -5.04 million, -6.19% less than in 2024.

Financial Statements

News

There is no news available yet.